Inhibition of the aspartyl protease BACE-1 has the potential to deliver a disease-modifying therapy for Alzheimer's disease. Herein, is described a series of potent inhibitors based on an hydroxyethylamine (HEA) transition state mimetic template. These inhibitors interact with the non prime side of the enzyme using a novel edge-to-face interaction with Arg-296.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2010.05.111 | DOI Listing |
Publication Analysis
Top Keywords
novel edge-to-face
8
edge-to-face interaction
8
interaction arg-296
8
bace-1 hydroxyethylamine
4
hydroxyethylamine inhibitors
4
inhibitors novel
4
arg-296 inhibition
4
inhibition aspartyl
4
aspartyl protease
4
protease bace-1
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!